相似文献
1
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases.
Biomedicines. 2024 Dec 24;13(1):4. doi: 10.3390/biomedicines13010004.
2
New Insights in Radiotherapy.
Biomedicines. 2022 Aug 9;10(8):1931. doi: 10.3390/biomedicines10081931.
3
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
5
Women's Special Issue Series: Biomedicines.
Biomedicines. 2024 Feb 20;12(3):471. doi: 10.3390/biomedicines12030471.
6
Precision medicine for respiratory diseases: A current viewpoint.
Med Int (Lond). 2024 Apr 12;4(4):31. doi: 10.3892/mi.2024.155. eCollection 2024 Jul-Aug.
7
Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches.
Biomedicines. 2022 Mar 7;10(3):623. doi: 10.3390/biomedicines10030623.
8
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models.
Eur J Pharmacol. 2022 Mar 15;919:174821. doi: 10.1016/j.ejphar.2022.174821. Epub 2022 Feb 11.
9
Parasitic Infection and Immunity-A Special Biomedicines Issue.
Biomedicines. 2022 Oct 12;10(10):2547. doi: 10.3390/biomedicines10102547.
10
Respiratory diseases call for special attention from clinical and translational science.
Transl Respir Med. 2013 Dec;1(1):1. doi: 10.1186/2213-0802-1-1. Epub 2013 Feb 22.
本文引用的文献
1
Cystic fibrosis.
Nat Rev Dis Primers. 2024 Aug 8;10(1):53. doi: 10.1038/s41572-024-00538-6.
2
Bronchiectasis.
Open Respir Arch. 2024 May 29;6(3):100339. doi: 10.1016/j.opresp.2024.100339. eCollection 2024 Jul-Sep.
3
Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives.
Int J Mol Sci. 2024 Jul 4;25(13):7347. doi: 10.3390/ijms25137347.
4
Phenotypes in pulmonary hypertension.
Eur Respir J. 2024 Sep 5;64(3). doi: 10.1183/13993003.01633-2023. Print 2024 Sep.
5
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Mol Cancer. 2024 May 30;23(1):115. doi: 10.1186/s12943-024-02014-x.
6
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU.
Am J Respir Crit Care Med. 2024 Jul 15;210(2):155-166. doi: 10.1164/rccm.202311-2086SO.
7
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.
Front Immunol. 2024 Mar 4;15:1344086. doi: 10.3389/fimmu.2024.1344086. eCollection 2024.
8
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
9
Malignant pleural effusion: current understanding and therapeutic approach.
Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7.
10
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.
Nat Cancer. 2024 Feb;5(2):347-363. doi: 10.1038/s43018-023-00694-w. Epub 2024 Jan 10.
Zotero 插件